STUDIES ON CEPHALOSPORIN ANTIBIOTICS

III. SYNTHESIS, ANTIBACTERIAL ACTIVITY AND ORAL ABSORPTION OF NEW 3-(SUBSTITUTED-ALKYLTHIO)-7j8-[(Z)-2-(2-AMINOTHIAZOL-4-YL)-
2-(CARBOXYMETHOXYIMINO)ACETAMIDO] CEPHALOSPORINS
Chihiro Yokoo, Masami Goi, Akira Onodera, Mitsuo Murata, Takatoshi Nagate and Yoshiaki Watanabe
Research Center, Taisho Pharmaceutical Co., Ltd., 1-403 Yoshino-cho, Omiya, Saitama 330, Japan (Received for publication January 5, 1991) The synthesis, antibacterial activity and oral absorption in rats of new 7/?-[(Z)-2-(2-aminothiazol-4-yl)-2-(carboxymethoxyimino)acetamido]cephalosporins (1) having various substituted-alkylthio groups at the C-3 position of the cephemnucleus are described. Of these, the cephalosporins with a cyanomethylthio group (Id) and fluoroethylthio group (lp) at the C-3 position showed a potent in vitro antibacterial activity against Gram-positive and Gram-negative bacteria as well as goodoral absorption in rats. Whenadministered orally to mice infected with Klebsiella pneumoniae, Id had stronger protective effect than lp. The structure-activity relationships of 1 are also presented.
In recent years, research on cephalosporin antibiotics having an aminothiazole-oximemoiety at the C-7 position of the cephem nucleus, so-called third generation cephalosporins, has been undertaken extensively due to their potent antibacterial activity and remarkable stability toward bacterial /Mactamases. However,there have been few reports1~3) on the analogues possessing a hetero-atom attached directly to the C-3 position.
In the course of our research program directed toward orally administered third generation cephalosporins such as cefixime4) and cefteram pivoxil5), we have already found that 7/?-[(Z)-2-(2-aminothiazol-4-yl)-2-(carboxymethoxyimino)acetamido]cephalosporins with an alkoxycarbonylmethoxy group at the C-3 position of the cephem nucleus, represented by 2 as shown in Fig. 1 , display good oral absorption in rats as well as potent antibacterial activities against Gram-negative bacteria6).
In connection with that work, we then designed the new analogues (1) (Fig. 1 ) having various substituted-alkylthio groups at the C-3 position, including the 3-thio congener of 2, in order to improve the activity of 2 against Staphylocoed. This paper describes the synthesis of 1, and the effects of the new 5-substituents at the C-3 position on antibacterial activity and oral absorption in rats.
Chemi stry The new cephalosporins (la~lq) were synthesized by the route as shown in Scheme 1. Diphenylmethyl (Bh) or /?-methoxybenzyl (PMB) 7j8-amino-3-methanesulfonyloxycephalosporinate (3)7) was coupled with the protected 2-aminothiazole-4-acetic acid derivative (4) in the presence of Tr=-CPh3, Ms=-SO2CH3, Bh=-CHPh2, X=Halogen, R^Bh or PMB, n=l or 2.
phosphorus oxychloride and pyridine in THFto afford the 7/?-acylaminocephalosporin derivative (5).
Subsequently, compound 5 was reacted with sodium hydrosulfide in DMF to give the 3-mercaptocephalosporin (6). After isolation or without isolation of 6, the 3-mercapto group in 6 was alkylated with various alkyl halides (7) in the presence of iV,JV-diisopropylethylamine as a base to yield the protected 3-substituted-alkylthio cephalosporins (8) (Method A). In this way, there was no formation of the zl2-isomer of 8.
Compound8 was also prepared from 5 by the alternative route using alkyl mercaptans (9) (Method B). However, considerable amounts of the zd2-isomer were formed during the reaction8).
Finally, the protecting groups in 8 were removed by the conventional method using TFAand anisole to afford the desired cephalosporin derivatives (1) . Antibacterial Activity and Oral Absorption The in vitro antibacterial activities of the new cephalosporins (1) against selected Gram-positive and Gram-negative bacteria and their peak serum levels as a measure of gastro-intestinal absorption after oral administration (50mg/kg) to rats are summarized in Table 1 . For comparison, the MICvalues and the peak serum levels of cefixime and 2 are listed at the bottom of Table 1 .
Against Staphylococcus aureus 209P JC-1 , the cephalosporins having the cyanomethylthio group (Id), benzylthio group (lh), or fluoroethyl group (Ip) at the C-3 position of the cephem nucleus showed more potent activity than the others. Andtheir activities were 4 to 8 times higher than those of cefixime and lr1>2) having an unsubstituted-alkylthio group (-SCH3) at the C-3 position. Judging from the comparison of the activity between 2 having a methoxycarbonylmethoxy group at the C-3 position and the corresponding 3-thio congener (la), it is clear that the sulfur atom directly attached to the C-3 position of the cephem nucleus plays an important role to enhance the antibacterial activity against S. aureus, probably due to the higher lipophilicity of the sulfur atom than that of the oxygen atom. On the other hand, against all the Gram-negative bacteria, these new compoundsexcept lc with an amino acid group at the C-3 position exhibited potent antibacterial activity comparable to cefixime and compound 2. Most of these new compounds displayed good oral absorption in rats. In particular, compounds Id and lp showed high peak serum levels after oral administration, and the peak serum level of Id was almost equal to that of cefixime. Contrary to our expectation, the oral absorption of la was muchlower than, that of the 3-oxy congener 2 in rats. The representative compounds in this series (Id and lp) possessing the potent in vitro antibacterial activity and good oral absorption in rats were then advanced to a preliminary in vivo efficacy trial by oral administration. As shown in Table 2 , the two compounds, particularly Id, showed good in vivo efficacy against a systemic infection in mice induced by Klebsiella pneumoniae 6, though less potent than that of cefixime.
In this study, we found some new orally administered cefixime type cephalosporins with improved activity against S. aureus by introduction of a substituted-alkylthio group into the C-3 position.
Further chemical modifications of the C-3 position of the cephalosporins are nowunder study to enhance still more the activity against StaphylococcL Experimental 501 Drugs were administered orally 1 hour after infection. Infective challenge dose: 2.9 x 107 cfu/mouse, ip, (5% mucin).
Mouse: Male ICR strain, 4 weeks, 10mice/group. a Probit method (95% confidence limits). b Inoculum size: 106cfu/ml.
MP's were determined with a Yanagimoto micro-melting point apparatus and are uncorrected. IR spectra were taken on a Jasco DS-701G IR spectrometer. XHNMR spectra were recorded on a Varian XL-200NMR spectrometer using TMSor sodium trimethylsilyl propionate-d^(in D2O) as an internal standard. Mass spectra (MS) were measured on a Jeol JMX-DX303 or JMS-SX102mass spectrometer. Most chromatographic separations were done using Wako Silica gel C-200 (100-200 mesh, Wako, Japan) or Sephadex LH-20 (Pharmacia, Sweden).
In Vitro and In Vivo Antibacterial Activities MICs were determined by the 2-fold agar dilution method using Sensitive Test agar (Eiken, Japan) after incubation at 37°C for 18 hours with an inoculum size of 106 cfu/ml. Mouse protecting experiments were conducted by use of male ICR mice («= 10) infected intraperitoneally with 0.5ml of a bacterial suspension containing 100%or more minimal lethal doses. Hog gastric mucin (5% w/v) was added to the suspension before injection. The test drugs in 5%gumarabic were administered orally 1 hour after the infection. Mortality of the animals was recorded daily over a period of 7 days and the ED50values were calculated by the method of probit9).
Oral Absorption Study Male SLC/Wister rats (n = 3) weighing 1 80~220 g were fasted overnight and orally dosed with 50 mg/kg of the test compounds. Serum samples were collected at 0.5, 1, 2 and 4hours, respectively, after dosing. Serum levels of the test compoundswere measured by the disc-plate method using Escherichia coli SC 507 or Micrococcusluteus NIHJas a test organism and Sensitive Test agar as the test medium.
To a solution of 7^-amino-3-methanesulfonyloxycephalosporanic acid Bh ester 3a7) (2.65 g, 5.76 him) in THF (80 ml) was added 2-(2-tritylaminothiazol-4-yl)-2-[(Z)»diphenylmethoxycarbonylmethoxyimino]-acetic acid (4) (4.14g, l.l equiv) and pyridine (1.37g, 3.0equiv) under ice-cooling.
After being stirred at -10°C, phosphorus oxychloride (1.76 g, 2.0equiv) was added dropwise to the solution, and the mixture was stirred at -10~-5°C for 20minutes. Then, brine (100ml) was added to the mixture and extracted with EtOAc (100ml). The extract was washed successively with 0.5% aq NaHCO3(50ml) and brine (100ml), dried (MgSO4)and evaporated. The residue was purified by column chromatography on silica gel (eluent; EtOAc-«-hexane, 1 : 1) to afford 4.56g (72%) of 5a as an amorphous solid: IR (KBr) cm"1 1795 (0-lactam) 
This compound was prepared from 3b (PMBester) in 75%yield as described for 5a from 3a. The 
To a solution of 5a (500mg, 0.46him) in DMF(5ml) were added 70% sodium hydrosulfide (41 mg, 1. 1 equiv) and iV,Af-diisopropylethylamine (89 mg, 1.5 equiv) dissolved in DMF(2 ml) at -5°C. After being stirred for 20minutes at the same temperature, chloroacetonitrile (69mg, 2.0equiv) was added to the solution at 0°C, and then stirred for 20 minutes at the same temperature. Subsequently, 0.5% HC1(10 ml) was added to the reaction mixture and extracted with EtOAc(20ml). The extract was washed with 0.5% aq NaHCO3 (10 ml) and brine (20 ml), successively, and then dried (MgSO4) and evaporated. The residue was purified by column chromatography on silica gel (eluent; EtOAc -«-hexane, 1 : 1) and crystallized from MeOH to give 385mg (78%) Compounds 8a, 8b, 8e~8n, 8p and 8q were similarly prepared from 5a or 5b with a corresponding substituted-alkyl halide 7 according to the procedure described for 8d. Their spectral data are summarized inTable3.
Diphenylmethyl 7^-[2-(2-Tritylaminothiazol-4-yl)-2-[(Z)-diphenylmethoxycarbonylmethoxyimino]
acetamido] -3 -mercapto-3 -cephem-4-carboxylate (6) After the reaction of 5a with sodium hydrosulfide according to the procedure for 8d, water was added to the reaction mixture and washed with Et2O. The aqueous layer was adjusted to pH 2 with 0.5% HC1 and extracted with EtOAc. The extract was washed with brine, dried (MgSO4) and evaporated. The residue was dissolved in a small amount of CH2C12,and added dropwise to isopropyl ether with stirring. The precipitate formed was collected by filtration to give 6 (85%) as a pale yellow powder: IR (KBr) cm"1 
To a solution of 5a (300mg, 0.27him) in CH3CN (5ml) were added D-iV-(ter*-Boc)cystein diphenylmethyl ester 9c (138mg, 1.3 equiv) and JV,7V-diisopropylethylamine (40mg, l.l equiv) under ice-cooling. After stirring for 2 hours at the same temperature, 0.5% HC1(5 ml) was added to the reaction mixture and extracted with EtOAc (10ml). The extract was washed with brine (10ml), and then dried (MgSO4) 
To a solution of the 3-(2-hydroxyethylthio) derivative 8m (400mg, 0.39nn) in CH2C12 (10ml) was added chlorosulfonyl isocyanate (0.044ml, 1.2equiv) at -30°C, and the reaction mixture was stirred for 15minutes at -10°C. Then, 20% aq Na2SO3 (5ml) was added to the mixture and stirred for lhour at room temperature. The separated organic layer was washed with brine (10mi x 3), dried (MgSO4) and evaporated. The residue was purified by column chromatography on silica gel (eluent; benzene -acetone, 7: 1) to yield 240mg (58%) of 8o as an amorphous solid: IR (KBr) cm "1 3240, 1775 (0-lactam) 
